Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Ahmad Tarhini
ECOG-ACRIN Cancer Research Group
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
938 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Cross Cancer Institute
Edmonton, Alberta, Canada
- Cancercare Manitoba
Winnipeg, Manitoba, Canada
- Health Sciences North
Greater Sudbury, Ontario, Canada
- Waterloo Regional Health Network
Kitchener, Ontario, Canada
- Ottawa Hospital and Cancer Center-General Campus
Ottawa, Ontario, Canada
- Odette Cancer Centre- Sunnybrook Health Sciences Centre
Toronto, Ontario, Canada
- University Health Network-Princess Margaret Hospital
Toronto, Ontario, Canada
- Chum - Centre Hospitalier de L'Universite de Montreal
Montreal, Quebec, Canada
- Mcgill University Department of Oncology
Montreal, Quebec, Canada
- University of Alabama at Birmingham Cancer Center
Birmingham, Alabama, United States
- Providence Hospital
Mobile, Alabama, United States
- University of South Alabama Mitchell Cancer Institute
Mobile, Alabama, United States
- Alaska Regional Hospital
Anchorage, Alaska, United States
- Providence Alaska Medical Center
Anchorage, Alaska, United States
- Fairbanks Memorial Hospital
Fairbanks, Alaska, United States
- Banner Md Anderson Cancer Center
Gilbert, Arizona, United States
- Banner University Medical Center - Tucson
Tucson, Arizona, United States
- University of Arizona Cancer Center-North Campus
Tucson, Arizona, United States
- University of Arizona Cancer Center-Orange Grove Campus
Tucson, Arizona, United States
- Mercy Hospital Fort Smith
Fort Smith, Arkansas, United States
- Nea Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro
Jonesboro, Arkansas, United States
- John L Mcclellan Memorial Veterans Hospital
Little Rock, Arkansas, United States
- University of Arkansas for Medical Sciences
Little Rock, Arkansas, United States
- Highlands Oncology Group - Rogers
Rogers, Arkansas, United States
- Kaiser Permanente-Deer Valley Medical Center
Antioch, California, United States
- Pcr Oncology
Arroyo Grande, California, United States
- Sutter Auburn Faith Hospital
Auburn, California, United States
- Sutter Cancer Centers Radiation Oncology Services-Auburn
Auburn, California, United States
- Sutter Cancer Centers Radiation Oncology Services-Cameron Park
Cameron Park, California, United States
- Sutter Davis Hospital
Davis, California, United States
- Kaiser Permanente-Fremont
Fremont, California, United States
- Kaiser Permanente-Fresno
Fresno, California, United States
- Saint Jude Medical Center
Fullerton, California, United States
- Marin Cancer Care Inc
Greenbrae, California, United States
- Uc San Diego Moores Cancer Center
La Jolla, California, United States
- Mattel Children'S Hospital Ucla
Los Angeles, California, United States
- the Angeles Clinic and Research Institute - West Los Angeles Office
Los Angeles, California, United States
- Ucla / Jonsson Comprehensive Cancer Center
Los Angeles, California, United States
- Kaiser Permanente-Modesto
Modesto, California, United States
- Memorial Medical Center
Modesto, California, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 17 Jun 2011
- Primary completion
- 15 Feb 2019
- Completion
- 2 Feb 2027
- Last update posted
- 2 Jul 2026
- Registered enrollment
- 1,673
- Registry id
- NCT01274338
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.